Skip to main content
MACH7 TECHNOLOGIES LIMITED logo

MACH7 TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · M7T ISIN · AU000000M7T0 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,192 across all filing types
Latest filing 2015-10-25 Investor Presentation
Country AU Australia
Listing ASX M7T

About MACH7 TECHNOLOGIES LIMITED

https://www.mach7t.com

Mach7 Technologies Limited specializes in enterprise imaging solutions for healthcare providers. The company develops software that enables the management, storage, and viewing of medical images and clinical data across diverse healthcare ecosystems. Its core offerings include the Mach7 Enterprise Imaging Platform, a Vendor Neutral Archive (VNA), and the eUnity Enterprise Viewer. These solutions are designed to provide a unified view of patient data, improving diagnostic workflows and clinical collaboration. Mach7's technology emphasizes interoperability, allowing integration with existing hospital systems and various imaging modalities. By decoupling data storage from viewing applications, the company offers a modular and scalable approach to medical data management, supporting large-scale healthcare networks and specialized diagnostic centers in optimizing their imaging infrastructure.

Recent filings

Filing Released Lang Actions
Investor Presentation on 3DM and Mach7 Merger 33 pages 1.2MB
Investor Presentation Classification · 95% confidence The document is titled '3D Medical Limited (ASX:3DM) Merger with Mach7 Technologies Investor Presentation 26 October 2015' and contains detailed information about the company overview, transaction overview, strategic rationale, transaction funding and impact, industry overview, and other related information. It includes forward-looking statements, disclaimers, and detailed descriptions of the acquisition and company highlights. The content is structured as a presentation aimed at investors, focusing on the merger transaction and strategic rationale rather than a formal regulatory filing or financial report. There is no indication that this is a full annual or interim report, audit report, earnings release, or other regulatory filing. The document is clearly an investor presentation related to a merger transaction, which fits the definition of 'Investor Presentation (IP)'. The length and detail also support this classification with high confidence.
2015-10-25 English
Dental Prosthetic Research Collaboration Agreement 2 pages 387.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 23 October 2015 about a Research Collaboration Agreement between 3D Medical Limited and a dental prosthetic manufacturer. It describes the nature of the collaboration and the potential commercial outcomes. The document is relatively short (3643 characters) and does not contain any financial statements, detailed financial data, or regulatory certifications. It is an announcement of a business collaboration rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any financial supplement. It is also not related to management changes, voting results, or legal proceedings. Given the content and length, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2015-10-22 English
Notice of Annual General Meeting/Proxy Form 19 pages 720.9KB
AGM Information Classification · 100% confidence The document is titled 'Notice of annual general meeting and explanatory memorandum' for 3D Medical Limited's 2015 Annual General Meeting. It includes details about the meeting date, venue, agenda items such as adoption of the remuneration report, re-election of directors, ratification of share issues, appointment of auditor, and approval of placement capacity. It also contains proxy voting instructions and shareholder question procedures. The document is a notice and explanatory memorandum for the AGM, not the actual annual report or financial statements. It is a presentation of materials and information shared for the AGM, consistent with the definition of AGM Information (AGM-R). The document length is substantial (15,000 characters), but it is clearly a meeting notice and explanatory document rather than a full financial report or other filing type.
2015-10-13 English
Annual Report to shareholders 62 pages 560.4KB
Regulatory Filings
2015-09-28 English
Appendix 4G and Corporate Governance Statement 26 pages 595.9KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G' and references ASX Listing Rules 4.7.3 and 4.10.3, which relate to corporate governance disclosures that must accompany the annual report. It includes a detailed key to disclosures against the ASX Corporate Governance Council Principles and Recommendations for the financial year ended 30 June 2015. The document is a corporate governance statement approved by the board and lodged with the ASX alongside the annual report. It does not contain full financial statements or comprehensive financial performance data but focuses on governance practices and compliance with governance recommendations. This type of document aligns with Governance Information filings, which detail internal rules, board structure, and governance practices. The document length (15,000 characters) and content confirm it is a substantive governance report, not merely an announcement or certification. Therefore, the appropriate classification is Governance Information (CGR).
2015-09-28 English
3D Medical accreditation milestone 4 pages 519.0KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 07 September 2015 from 3D Medical Limited. It discusses milestones such as ISO accreditation progress, commissioning of a new Selective Laser Melting (SLM) metal printer, and a service level agreement with another company (333D). The content focuses on operational updates, technology deployment, and partnership agreements rather than financial results, management changes, or regulatory filings. There is no indication of financial statements, earnings data, or detailed management discussion. The document is a corporate announcement about business developments and operational milestones. Therefore, it fits best under the category of Capital/Financing Update (CAP) as it relates to company operational capacity and strategic agreements that impact production capabilities and business growth potential.
2015-09-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.